Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02993731
Title A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma (CanStem111P)
Acronym CanStem111P
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | ITA | FRA | ESP | DEU | CZE | CAN | BEL | AUT | AUS


No variant requirements are available.